Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology · APP-Related Amyloidosis

Symptoms, "Amyloid Spells," and Medical Emergencies

At a Glance

In APP-related amyloidosis, brief spreading tingling or visual symptoms can be amyloid spells, but new, prolonged, or unusual symptoms may signal bleeding. Sudden severe headache, weakness, speech trouble, or seizures require emergency care; tell clinicians before blood thinners are considered.

Understanding the symptoms of APP-related amyloidosis is vital because some events that look like emergencies—such as “mini-strokes”—may actually be a different phenomenon that requires a very different medical response. While many symptoms are not emergencies, knowing how to distinguish between a “spell” and a true bleed is critical for your safety.

What is NOT an Emergency

Many people with APP-related amyloidosis live with ongoing symptoms that, while challenging, do not require a trip to the Emergency Room:

  • Gradual Memory or Cognitive Changes: Slow changes in your ability to plan, remember names, or follow complex conversations are expected parts of the disease spectrum [1][2].
  • Mild Behavioral Shifts: Subtle changes in personality or mood [1].
  • Known Migraine Patterns: If you have a history of migraines and your current headache feels like your “usual” migraine with a typical aura, this is generally not an emergency [3].

The “Amyloid Spell”: TFNEs

One of the most confusing symptoms of this condition is the Transient Focal Neurological Episode (TFNE), often called an “amyloid spell” [4]. These spells are brief (often lasting 10–30 minutes) and can look exactly like a TIA (Transient Ischemic Attack or mini-stroke) [5][6].

How to recognize an Amyloid Spell:

  • The “March”: Unlike a stroke, which usually causes a sudden loss of function (like a numb arm), a spell often involves “positive” symptoms that spread or “march” across the body. For example, tingling that starts in your fingers and moves up your arm over several minutes [6][7].
  • Visual Disturbance: You might see flashing lights, zig-zag lines, or shimmering spots that move across your field of vision [5].
  • Recurrence: These spells are often “stereotyped,” meaning you might have the exact same tingling or visual sensation several times over a few days [6][8].

The Critical Danger: Misdiagnosis

The greatest risk of an “amyloid spell” is not the spell itself, but the treatment a doctor might give if they think you are having an acute stroke.

  • The Ischemic Stroke Trap: If a doctor suspects an acute ischemic stroke (a clot blocking blood flow), they may consider “clot-busting” drugs (tPA) or strong anticoagulants to restore flow [9].
  • The Risk: For someone with APP-related amyloidosis, these drugs can be extremely dangerous. Because your blood vessels are fragile from amyloid buildup, thrombolytics or strong blood thinners carry a high risk of triggering a life-threatening brain hemorrhage [10][11].

If you go to the ER for a “spell,” you must tell the doctors immediately that you have APP-related amyloidosis and that blood thinners are high-risk for you. Do not refuse a rapid CT scan or stop medicines on your own; let the stroke team review your history to weigh the risks safely.

Tier 1: Emergency Services (Call 911)

Go to the hospital immediately for any of the following, as they may indicate an Intracerebral Hemorrhage (ICH)—a bleed in the brain:

  • Sudden, Severe “Thunderclap” Headache: The worst headache of your life, starting abruptly [12].
  • Sudden Weakness or Slurred Speech: Any new, sudden loss of strength on one side of the body or difficulty speaking [12].
  • Seizures: New shaking, loss of consciousness, or “blanking out” [1].
  • Prolonged Migraine Aura: For those with the Dutch-type variant, if a migraine aura (visual changes, tingling) lasts longer than 60 minutes, it is a major warning sign. Research in one Dutch-type cohort showed that 55% of these long auras were actually signs of a brain bleed [3].

Tier 2: Emergency or Urgent Medical Evaluation

Go to the ER or contact your neurology team immediately if you experience:

  • A “New” Spell: If you have never had a “march” of tingling or visual spots before, you need an urgent evaluation to check for convexity subarachnoid hemorrhage (cSAH)—a small leak of blood on the brain’s surface that often causes these spells [13][14]. Any new, persistent, or atypical focal symptom requires emergency assessment.
  • Change in Seizure Frequency: If you have known seizures and they are becoming more frequent or changing in nature.

Tier 3: Routine Appointment

Discuss these at your next scheduled visit:

  • Slowly worsening memory or confusion [1].
  • Difficulty with complex tasks at home or work.
  • Mild, familiar headaches that respond to your usual treatments.
Symptom Likely Cause Action
Tingling that “marches” for 15 mins (new) Amyloid Spell (TFNE) / cSAH Emergency Assessment
Aura lasting >60 mins (Dutch-type) Potential Bleed (ICH) Emergency Room
Sudden one-sided weakness Potential Bleed (ICH) Emergency Room
Gradual trouble managing bills Cognitive Decline Routine Appointment

Note on Imaging: If you are in the ER, request a blood-sensitive MRI (such as GRE or SWI sequences) as a follow-up. These are much better than a standard CT scan at finding the small “microbleeds” or iron deposits (hemosiderin) that confirm your condition and help doctors avoid dangerous medications, though CT is usually done first [13][15].

Common questions in this guide

What is an amyloid spell in APP-related amyloidosis?
An amyloid spell is a brief transient focal neurological episode that may cause tingling, numbness, or visual symptoms to spread or “march” over several minutes. It can resemble a mini-stroke, and a first, unusual, or persistent episode needs urgent medical assessment.
Which symptoms mean I should call 911?
Call 911 for a sudden, severe thunderclap headache, new one-sided weakness, slurred speech, a seizure, loss of consciousness, or another sudden neurological change. In people with a Dutch-type APP variant, an aura lasting longer than 60 minutes is also a major warning sign and needs emergency evaluation.
Can an amyloid spell look like a TIA or stroke?
Yes. An amyloid spell may cause spreading tingling or moving visual symptoms, while a stroke more often causes sudden loss of function, but the difference cannot be confirmed safely at home. Any new, atypical, or persistent symptom should be assessed urgently.
Why do emergency doctors need to know about APP-related amyloidosis before giving blood thinners?
Amyloid can make brain blood vessels fragile, so thrombolytic drugs and strong anticoagulants may raise the risk of a life-threatening brain hemorrhage. Tell the emergency team about the diagnosis immediately, but do not delay a CT scan or stop prescribed medicines without medical guidance.
Which scans can detect small bleeds in APP-related amyloidosis?
CT is often performed first during an emergency to look for an acute brain bleed. A blood-sensitive MRI using GRE or SWI sequences can better show microbleeds, hemosiderin, and cortical superficial siderosis, which help clinicians assess the condition and treatment risks.
How can I tell a familiar migraine aura from a dangerous symptom?
A familiar aura that follows your usual pattern may not be an emergency, but a new, prolonged, or changing aura needs urgent evaluation. For people with a Dutch-type APP variant, an aura lasting more than 60 minutes can signal a brain bleed; sudden weakness, speech trouble, severe headache, or seizures require emergency care.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on APP-related brain and vascular amyloidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If I experience a 'march' of tingling or numbness, should I go to the ER even if it only lasts a few minutes?
  2. 2.Do you have experience treating patients with Dutch-type or other APP mutations where 'amyloid spells' are common?
  3. 3.If I am ever brought to an ER for suspected stroke, how can we ensure the medical team reviews my history before giving treatments?
  4. 4.Can we review my most recent MRI specifically looking for 'cortical superficial siderosis' or signs of small bleeds?
  5. 5.For my specific mutation, how should I distinguish between a standard migraine aura and a potential brain bleed?

References

References (15)
  1. 1

    Phenotype and imaging features associated with APP duplications.

    Grangeon L, Charbonnier C, Zarea A, et al.

    Alzheimer's research & therapy 2023; (15(1)):93 doi:10.1186/s13195-023-01172-2.

    PMID: 37170141
  2. 2

    Cerebral amyloid angiopathy as a cause of neurodegeneration.

    Smith EE

    Journal of neurochemistry 2018; (144(5)):651-658 doi:10.1111/jnc.14157.

    PMID: 28833176
  3. 3

    Migraine With Aura as Early Disease Marker in Hereditary Dutch-Type Cerebral Amyloid Angiopathy.

    Koemans EA, Voigt S, Rasing I, et al.

    Stroke 2020; (51(4)):1094-1099 doi:10.1161/STROKEAHA.119.028170.

    PMID: 32114932
  4. 4

    Cerebral Amyloid Angiopathy-Related Transient Focal Neurologic Episodes.

    Smith EE, Charidimou A, Ayata C, et al.

    Neurology 2021; (97(5)):231-238 doi:10.1212/WNL.0000000000012234.

    PMID: 34016709
  5. 5

    Primary acute convexity subarachnoid hemorrhage in older patients: analysis of baseline, clinical and MRI characteristics including quantitative surface study and topographical probabilistic mapping of convexity subarachnoid hemorrhage.

    Autieri V, Gaillard N, Mourand I, et al.

    Acta neurologica Belgica 2023; (123(2)):519-527 doi:10.1007/s13760-022-02115-8.

    PMID: 36241843
  6. 6

    Clinical features distinguish cerebral amyloid angiopathy-associated convexity subarachnoid haemorrhage from suspected TIA.

    Stanton JED, Chandratheva A, Wilson D, et al.

    Journal of neurology 2020; (267(1)):133-137 doi:10.1007/s00415-019-09558-9.

    PMID: 31583428
  7. 7

    Cerebral Microbleeds and Cortical Superficial Siderosis in Patients Presenting With Minor Cerebrovascular Events.

    Zerna C, Modi J, Bilston L, et al.

    Stroke 2016; (47(9)):2236-41 doi:10.1161/STROKEAHA.116.013418.

    PMID: 27507863
  8. 8

    Recurrent migraine aura-like symptoms in an elderly woman: symptomatic cortical spreading depression?

    Glössmann K, Baumgartner C, Koren JP, Riederer F

    BMJ case reports 2021; (14(7)) doi:10.1136/bcr-2020-241479.

    PMID: 34226251
  9. 9

    Fatal Outcome of Intravenous Thrombolysis With an Unexpected Finding of Amyloid-β-Related Angiitis-A Case Report Highlighting a Relevant Scenario With Acute Focal Neurological Deficits and Minimal Radiological Presentation.

    Babarczy K, Radics BL, Horvath O, et al.

    Neuropathology : official journal of the Japanese Society of Neuropathology 2025; (45(4)):e70013 doi:10.1111/neup.70013.

    PMID: 40474363
  10. 10

    Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke.

    Marzoughi S, Alhabli I, Singh N, et al.

    Stroke 2026; (57(4)):933-944 doi:10.1161/STROKEAHA.125.054654.

    PMID: 41608814
  11. 11

    Transient Focal Neurological Events in Cerebral Amyloid Angiopathy and the Long-term Risk of Intracerebral Hemorrhage and Death: A Systematic Review and Meta-analysis.

    Sanchez-Caro JM, de Lorenzo Martínez de Ubago I, de Celis Ruiz E, et al.

    JAMA neurology 2022; (79(1)):38-47 doi:10.1001/jamaneurol.2021.3989.

    PMID: 34779831
  12. 12

    Cerebral Amyloid Angiopathy Presenting as Lobar Intracerebral Hemorrhage with Cognitive Decline in an 80-Year-Old Patient: A Clinicoradiologic Case Report.

    Tarabocchia R, Javaid K, Mittal R, et al.

    Reports (MDPI) 2026; (9(2)) doi:10.3390/reports9020191.

    PMID: 42347104
  13. 13

    Acute Convexity Subarachnoid Hemorrhage Related to Cerebral Amyloid Angiopathy: Clinicoradiological Features and Outcome.

    Calviere L, Cuvinciuc V, Raposo N, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2016; (25(5)):1009-1016 doi:10.1016/j.jstrokecerebrovasdis.2015.11.010.

    PMID: 26923093
  14. 14

    Cerebral amyloid angiopathy-related transient focal neurological episodes: A transient ischemic attack mimic with an increased risk of intracranial hemorrhage.

    Vales-Montero M, García-Pastor A, Iglesias-Mohedano AM, et al.

    Journal of the neurological sciences 2019; (406()):116452 doi:10.1016/j.jns.2019.116452.

    PMID: 31525529
  15. 15

    Late onset aura may herald cerebral amyloid angiopathy: A case report.

    Samanci B, Coban O, Baykan B

    Cephalalgia : an international journal of headache 2016; (36(10)):998-1001 doi:10.1177/0333102415620253.

    PMID: 26611682

This page is for informational purposes only and does not constitute medical advice about APP-related amyloidosis. Sudden neurological symptoms require emergency evaluation; do not start or stop blood thinners without medical guidance.